Article
An Integrated Molecular Analysis of Lung Adenocarcinomas Identifies Potential Therapeutic Targets among TTF1-Negative Tumors, Including DNA Repair Proteins and Nrf2.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Aug 2015
Cardnell Robert J G, Behrens Carmen, Diao Lixia, Fan YouHong, Tang Ximing, Tong Pan, Minna John D, Mills Gordon B, Heymach John V, Wistuba Ignacio I, Wang Jing, Byers Lauren A
Abstract excerpt
PURPOSE: Thyroid transcription factor-1 (TTF1) immunohistochemistry (IHC) is used clinically to differentiate primary lung adenocarcinomas (LUAD) from squamous lung cancers and metastatic adenocarcinomas from other primary sites. However, a subset of LUAD (15%-20%) does not express TTF1, and TTF1-negative patients have worse clinical outcomes. As there are no established targeted agents with activity in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
